Literature DB >> 1963128

An empirical study of the possible relation of treatment differences to quality scores in controlled randomized clinical trials.

J D Emerson1, E Burdick, D C Hoaglin, F Mosteller, T C Chalmers.   

Abstract

Meta-analytic investigations sometimes use assessments of research quality according to a formal protocol as a tool for improving research synthesis. We asked whether a particular quality scoring system could have a direct use in adjusting the summary estimates of a treatment difference. In an empirical study of the relation of quality scores to treatment differences in published meta-analyses of 7 groups of controlled randomized clinical trials comprising 107 primary studies, we found no relation between treatment difference and overall quality score. We also found no relation between quality score and variation in treatment difference. The level of quality scores has increased at a rate of 9% per decade for three decades, averaging 0.51 on a scale of 0 to 1 for the 1980s, and leaving much room for improvement. Nevertheless, attention to quality of studies by editors, reviewers, and authors may be raising both the level of research done and quality of the reports.

Mesh:

Year:  1990        PMID: 1963128     DOI: 10.1016/0197-2456(90)90175-2

Source DB:  PubMed          Journal:  Control Clin Trials        ISSN: 0197-2456


  42 in total

Review 1.  Which guidelines can we trust?: Assessing strength of evidence behind recommendations for clinical practice.

Authors:  A Liberati; R Buzzetti; R Grilli; N Magrini; S Minozzi
Journal:  West J Med       Date:  2001-04

2.  Considerations for the design and analysis of experimental studies in physical activity and exercise promotion: advantages of the randomised controlled trial.

Authors:  S S Tai; S Iliffe
Journal:  Br J Sports Med       Date:  2000-06       Impact factor: 13.800

3.  Adequacy and reporting of allocation concealment: review of recent trials published in four general medical journals.

Authors:  Catherine Hewitt; Seokyung Hahn; David J Torgerson; Judith Watson; J Martin Bland
Journal:  BMJ       Date:  2005-03-10

Review 4.  Use of statins and risk of haematological malignancies: a meta-analysis of six randomized clinical trials and eight observational studies.

Authors:  Stefanos Bonovas; Kalitsa Filioussi; Argirios Tsantes; Nikolaos M Sitaras
Journal:  Br J Clin Pharmacol       Date:  2007-06-19       Impact factor: 4.335

5.  Methodological quality of randomised controlled trials comparing short-term results of laparoscopic and conventional colorectal resection.

Authors:  Wolfgang Schwenk; Oliver Haase; Nina Günther; Jens Neudecker
Journal:  Int J Colorectal Dis       Date:  2007-05-26       Impact factor: 2.571

6.  Management of confounding in controlled orthopaedic trials: a cross-sectional study.

Authors:  Patrick Vavken; Georg Culen; Ronald Dorotka
Journal:  Clin Orthop Relat Res       Date:  2008-02-21       Impact factor: 4.176

7.  PREOP: development of an evidence-based expert system to assist with preoperative assessments.

Authors:  A M Holbrook; K B Langton; R B Haynes; A Mathieu; S Cowan
Journal:  Proc Annu Symp Comput Appl Med Care       Date:  1991

8.  The use of confidence intervals in reporting orthopaedic research findings.

Authors:  Patrick Vavken; Klemens M Heinrich; Christian Koppelhuber; Stefan Rois; Ronald Dorotka
Journal:  Clin Orthop Relat Res       Date:  2009-03-31       Impact factor: 4.176

9.  Can statin therapy reduce the risk of melanoma? A meta-analysis of randomized controlled trials.

Authors:  Stefanos Bonovas; Georgios Nikolopoulos; Kalitsa Filioussi; Evangelia Peponi; Pantelis Bagos; Nikolaos M Sitaras
Journal:  Eur J Epidemiol       Date:  2009-10-21       Impact factor: 8.082

10.  The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials.

Authors:  R Kunz; A D Oxman
Journal:  BMJ       Date:  1998-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.